17 September 2019

Latest update on HIV and COVID-19 from BHIVA and EACS (January 2021) 15 January 2021
Baseline NNRTI resistance linked to poorer response to first-line dolutegravir in the ADVANCE study 14 January 2021
Monoclonal antibody bamlanivimab is not effective in advanced COVID-19: lack of early signal stops study early 10 January 2021
Novavax phase 3 vaccine study launched in the UK, South Africa, US, Mexico and Puerto Rico 10 January 2021
All early access reports

Current issues

January 2021
December 2020
November 2020
Back issues

Special report

Early results report 90% efficacy with from Pfizer/BioNTech COVID vaccine 11 November 2020

More from HTB

Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage

Home

i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

This site complies with the HONcode standard for trustworthy health information.

Verify here.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links: HIV positive; Advocate; Professional; Donate; Feedback

Advice and information: Q and A; Phoneline; Pocket info; Guides; HIV meds; Glossary

Research and conference reports: HTB; HTB South; Pipeline report

Publications and resources: Publications; Other resources; Translations; Slide sets; Order and subscribe

News and updates: News; Blogs

Advocates' network: UK-CAB; Training manual

i-Base: About us; Contact; Sitemap; Home

Find us on Facebook

17 September 2019

Contents

Conference reports